GFAP and autoimmune disease: Despite extensive investigation ruling out infectious and autoimmune diseases, bone marrow biopsy, and CSF cytology, elevated levels of anti-GFAP antibodies were detected early in the disease and decreased during remission, as observed using a cell-based assay.